Regulation of calcium homeostasis during pregnancy is complex. Clinically s
ignificant bone mass loss is infrequent; however a subset of women may deve
lop symptomatic osteoporosis related to pregnancy. Lactation is a period of
special risk for bone loss. Whatever the effect of heparin on bone loss, v
ertebral fractures are rare in women treated with heparin during pregnancy,
Low molecular weight heparins may have a less deleterious effect on bone t
han unfractionated heparin. Women with autoimmune diseases, particularly th
ose with lupus and/or the antiphospholipid syndrome may receive heparin thr
oughout pregnancy. Corticosteroids must be reduced as much as possible in t
hese women, and calcium plus vitamin D are recommended. Finally, indication
s for heparin use must be clearly justified and advice regarding breastfeed
ing must be offered.